Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Bold Colors, Playful Shapes, Handmade Textures: This Mexico City Home Is 100% Joyful! - 2Building an Individual Brand: Illustrations from Powerhouses
- 3Invigorating Spots To Go Kayaking All over The Planet
- 4SpaceX launches Starlink satellites from California on 160th Falcon 9 flight of the year (video)
- 5Watch SpaceX launch powerful ocean-mapping satellite for Europe and NASA early Nov. 17
- Bayer reports positive results for blood thinner after 2023 setback
- Happy with Running Shoes for 2024
- What's The Friendliest City In The United Kingdom?
- Germany ready to assist Syria's reconstruction, says foreign minister
- All that You Really want to Be familiar with Dental Inserts Facilities
- 5 Signs Now is the ideal time to Update Your Android Telephone: When to Take the Action
- Consumer experts: German petrol hikes rule won't bring down prices
- Nigeria’s return to Windsor castle signals new era in UK economic partnership
- China Just Got Another Cheap EV America Would Love to Have
